PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27748864-2	2016	The antitumor pharmacological effects of BA consist of triggering apoptosis via the mitochondrial pathway, regulating the cell cycle and the angiogenic pathway via factors, including specificity protein transcription factors, cyclin D1 and epidermal growth factor receptor, inhibiting the signal transducer and activator of transcription 3 and nuclear factor-kappaB signaling pathways, preventing the invasion and metastasis of tumor cells, and affecting the expression of topoisomerase I, p53 and lamin B1.	betulinic acid	41-43	cyclin D1	Homo sapiens	226-235	
33719271-10	2020	Conclusion: The betulinic acid regulates the proliferation of SGC-7901 cells by inhibiting the expressions of cyclin D1 and cyclin B1, which leads to cell cycle arrest and proliferative inhibition.	betulinic acid	16-30	cyclin D1	Homo sapiens	110-119	
34374237-6	2021	Conclusion: At a final concentration of 10~30 mug/ml, betulinic acid can reduce the proliferation of human gastric cancer MGC-803 cells, inhibit cell growth, and down-regulate the expression of CCNB1 and CCND1 to block human gastric cancer MGC-803 cells in the S phase.	betulinic acid	54-68	cyclin D1	Homo sapiens	204-209	
19937797-6	2010	Betulinic acid also downregulated the expression of STAT3-regulated gene products such as bcl-xL, bcl-2, cyclin D1 and survivin.	betulinic acid	0-14	cyclin D1	Homo sapiens	105-114	
26013878-0	2016	PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3beta and cyclin D1 and potentially checks cancer cell proliferation.	betulinic acid	44-58	cyclin D1	Homo sapiens	129-138